SCHEMBL21666764

SCHEMBL21666764

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc3c(c2)oc2cccc(-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)c23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.35
MEN1 O00255 7/20 0.35
KMT2A Q03164 7/20 0.35
ALDH1A1 P00352 6/20 0.35
HPGD P15428 6/20 0.35
NTSR1 P30989 1/20 0.35
LMNA P02545 4/20 0.34
KDM4E B2RXH2 4/20 0.34
GLA P06280 1/20 0.34
MAOB P27338 3/20 0.32
MAOA P21397 2/20 0.32
TDP1 Q9NUW8 3/20 0.32
CYP2C19 P33261 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MAPK10 P53779 1/20 0.32
MAPK1 P28482 3/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21666763 0.97 MEN1 (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21667131 0.97 MEN1 (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23026224 0.97 MEN1 (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21671361 0.94 MAPT (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21667125 0.93 MAPT (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21666765 0.92 MEN1 (0.34) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23026237 0.91 KDM4E (0.31) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21671533 0.91 PTGER4 (0.32) PTGER4
SCHEMBL21671123 0.91 MAPT (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL21666800 0.91 PTGER4 (0.32) PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257586-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-10-11 EP disclosed
US-11785844-B2 Organic light emitting device, method for manufacturing same and composition for organic material layer LT MATERIALS CO., LTD. (KR) 2023-10-10 US disclosed
US-11785844-B2 Organic light emitting device, method for manufacturing same and composition for organic material layer LT MATERIALS CO., LTD. (KR) 2023-10-10 US disclosed
US-11527723-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2022-12-13 US disclosed
EP-3604296-B1 ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT LT MATERIALS CO LTD (KR) 2021-07-28 EP disclosed
US-20210057651-A1 ORGANIC LIGHT EMITTING DEVICE, METHOD FOR MANUFACTURING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2021-02-25 US disclosed
US-20200123133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-04-23 US disclosed
EP-3604298-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME Heesung Material Ltd. (KR) 2020-02-05 EP disclosed
EP-3604296-A1 ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT Heesung Material Ltd. (KR) 2020-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200123133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 MAPT 1487/4885MEN1 351/4885KMT2A 592/4885
US-11527723-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, CYP1A1 MAPT 1487/4885MEN1 351/4885KMT2A 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.